Eric Still
Impact in
-
- Acute Myeloid Leukemia Research
-
- CRISPR and Genetic Engineering
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
- DNA Repair Mechanisms
- Advanced biosensing and bioanalysis techniques
Papers in
-
- Advanced biosensing and bioanalysis techniques 2
- Protein Degradation and Inhibitors 1
- Sphingolipid Metabolism and Signaling 1
- Oncology 2
- Cancer Treatment and Pharmacology 1
- Cancer-related Molecular Pathways 1
- Co-authors
- Alex Kentsis (3 shared papers)Fiona C. Brown (2 shared papers)Richard P. Koche (1 shared paper)Tatyana Gindin (1 shared paper)Michael G. Kharas (1 shared paper)Gerard Minuesa (1 shared paper)Andrei V. Krivtsov (1 shared paper)Scott A. Armstrong (1 shared paper)
- Journals
- Blood (1 paper)British Journal of Haematology (1 paper)eLife (1 paper)International Journal of Oncology (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Eric Still
7 papers receiving 181 citations
Peers
Comparison fields: 5 of 50
- Hematology 41
- Molecular Biology 148
- Cancer Research 28
- Oncology 34
- Genetics 9
Countries citing papers authored by Eric Still
This map shows the geographic impact of Eric Still's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Still with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Still more than expected).
Fields of papers citing papers by Eric Still
This network shows the impact of papers produced by Eric Still. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Still. The network helps show where Eric Still may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Still, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 68 | |
| 2 | 2015 | 57 | |
| 3 | 2012 | 22 | |
| 4 | 2016 | 21 | |
| 5 | 2013 | 8 | |
| 6 | 2013 | 6 | |
| 7 | 2010 | 1 |
About Eric Still
Eric Still is a scholar working on Molecular Biology, Oncology, Hematology, Infectious Diseases and Pathology and Forensic Medicine, having authored 7 papers that have together received 183 indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (2 papers), Cancer Treatment and Pharmacology (1 paper), Protein Degradation and Inhibitors (1 paper), Sphingolipid Metabolism and Signaling (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Cancer-related Molecular Pathways (1 paper), Genetic factors in colorectal cancer (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Hematology (41 citations), Molecular Biology (148 citations), Cancer Research (28 citations), Oncology (34 citations) and Genetics (9 citations). Eric Still has collaborated with scholars based in United States and China. Frequent co-authors include Alex Kentsis, Fiona C. Brown, Richard P. Koche, Tatyana Gindin, Michael G. Kharas, Gerard Minuesa, Andrei V. Krivtsov, Scott A. Armstrong, Lauren Forbes and Elisa de Stanchina. Their work appears in journals such as Blood, British Journal of Haematology, eLife, International Journal of Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.